HMGB2 and Alzheimer disease: In particular, the expression of Dio2, that activates myelination, and of HMGB2 which controls the amyloid-β plaque clearance, is altered in AD (Calza et al., 2002; Gao et al., 2011; Humphries et al., 2015; Yamanaka et al., 2015).